Takashi Okada
4h ago
medicinepharmacologypsychiatryschizophrenia
IntroductionIn the treatment of schizophrenia, antipsychotics used during acute inpatient care must control acute symptoms while remaining sufficiently tolerable to support treatment beyond the acute phase. Brexpiprazole, a serotonin-dopamine activity modulator may be one such option; however, its real-world use and short-term continuation in acute inpatient settings remain insufficiently charact…
The post The Predicted Long-Term Benefits of Ensuring Timely Treatment and Medication Adherence in Early Schizophrenia appeared first on Center for Economic and Social Research .
The post Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia appeared first on Center for Economic and Social Research .
The post Simulated long-term outcomes of early use of long-acting injectable antipsychotics in early schizophrenia appeared first on Center for Economic and Social Research .
The post Improving Antipsychotic Adherence Among Patients With Schizophrenia: Savings for States appeared first on Center for Economic and Social Research .